Dominant clonotypes within HIV-specific T cell responses are programmed death-1high and CD127low and display reduced variant cross-reactivity.
about
Role of PD-1 in HIV pathogenesis and as target for therapyTCR affinity associated with functional differences between dominant and subdominant SIV epitope-specific CD8+ T cells in Mamu-A*01+ rhesus monkeysProgrammed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load.B cell responses to HIV antigen are a potent correlate of viremia in HIV-1 infection and improve with PD-1 blockadeClonotype and repertoire changes drive the functional improvement of HIV-specific CD8 T cell populations under conditions of limited antigenic stimulation.Dynamic Perturbations of the T-Cell Receptor Repertoire in Chronic HIV Infection and following Antiretroviral TherapyCross-reactivity of T cells and its role in the immune systemMultiparameter analysis of stimulated human peripheral blood mononuclear cells: A comparison of mass and fluorescence cytometry.Functional avidity: a measure to predict the efficacy of effector T cells?PD-1 coinhibitory signals: the link between pathogenesis and protection.Preserving HIV-specific T cell responses: does timing of antiretroviral therapy help?Characterization of High-Avidity Cytomegalovirus-Specific T Cells with Differential Tetramer Binding Coappearing after Allogeneic Stem Cell Transplantation.Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors.Partial recovery of senescence and differentiation disturbances in CD8+ T cell effector-memory cells in HIV-1 infection after initiation of anti-retroviral treatment.Cytomegalovirus (CMV) Epitope-Specific CD4(+) T Cells Are Inflated in HIV(+) CMV(+) Subjects.Antiretroviral therapy reduces the magnitude and T cell receptor repertoire diversity of HIV-specific T cell responses without changing T cell clonotype dominance.T Cell Receptor Profiling in Type 1 Diabetes.Therapeutic conserved elements (CE) DNA vaccine induces strong T-cell responses against highly conserved viral sequences during simian-human immunodeficiency virus infection.
P2860
Q24634293-DC27829C-8AD7-43E8-86CC-572DD49F7456Q27329011-8746B6DC-5E2B-4963-B2D9-AE7380E3283FQ34197037-1D66483A-540A-47F2-A21A-0874D6441417Q35073276-FB9AF0C9-E1E3-4DF9-9A0C-7302515F7979Q35685446-94DAEB5C-8801-479B-98AA-8C444B411F7EQ36448225-1EB1CFAE-78EF-4199-8CC3-A4A0CE87382EQ36678774-431306B3-0485-4EA1-9A91-B649768884E0Q36730456-2B36DDC3-623E-4D7D-B696-CF071F6C1ACAQ38066211-26191FBD-B83D-4D8C-BDA0-4B23A28DAEE6Q38095246-BA858771-625A-4CA1-BBEF-62F3B21A6E00Q38267445-8C1C69B0-10CA-494A-8EA8-E19F4BC10163Q38718441-63F90B51-76C6-4E1E-B4CD-7AC77A0E9835Q40615883-E0CE3469-0C23-4435-882C-75F4F0711C8EQ40625713-B57DCE55-30A9-47CC-A26C-A3291FF6C66CQ41991727-283AB34E-15DD-42C4-9DD8-D8FE7B99A2B6Q42060944-1962F0A4-6AEB-4C77-8F6F-B0D0455F891EQ42374922-EA78106E-9B06-4626-84BA-7A10E18D40D5Q52592228-06F1F9A6-BF3D-4FD8-8599-1DEC59CDDBCA
P2860
Dominant clonotypes within HIV-specific T cell responses are programmed death-1high and CD127low and display reduced variant cross-reactivity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Dominant clonotypes within HIV ...... uced variant cross-reactivity.
@en
Dominant clonotypes within HIV ...... uced variant cross-reactivity.
@nl
type
label
Dominant clonotypes within HIV ...... uced variant cross-reactivity.
@en
Dominant clonotypes within HIV ...... uced variant cross-reactivity.
@nl
prefLabel
Dominant clonotypes within HIV ...... uced variant cross-reactivity.
@en
Dominant clonotypes within HIV ...... uced variant cross-reactivity.
@nl
P2093
P2860
P356
P1476
Dominant clonotypes within HIV ...... duced variant cross-reactivity
@en
P2093
Brenna C Simons
Dirk Meyer-Olson
Louise Barnett
Ramesh K Ramalingam
Rita M Smith
Shanmugalakshmi Sadagopal
Shelly L Lorey
Spyros A Kalams
P2860
P304
P356
10.4049/JIMMUNOL.1004234
P407
P577
2011-05-11T00:00:00Z